Aromasin is a brand name for the medication exemestane, which belongs to a class of drugs known as aromatase inhibitors. Aromatase inhibitors are primarily used in the treatment of breast cancer, particularly in postmenopausal women whose tumors are hormone receptor-positive.
Aromasin works by inhibiting the enzyme aromatase, which is responsible for converting androgens (male hormones) into estrogen (female hormone). By blocking this conversion, Aromasin reduces the levels of estrogen in the body. In hormone receptor-positive breast cancer, estrogen can stimulate the growth of cancer cells. Therefore, lowering estrogen levels can help slow down or stop the growth of breast cancer cells.
In summary, Aromasin decreases estrogen levels in the body by inhibiting aromatase, which is beneficial in the treatment of hormone receptor-positive breast cancer.
